IRVINE, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial ...

CHICAGO (AP) — CHICAGO (AP) — Xeris Biopharma Holdings, Inc. (XERS) on Thursday reported a loss of $5.1 million in its fourth quarter. The Chicago-based company said it had a loss of 3 cents ...

Connor Clark & Lunn Investment Management Ltd. raised its stake in shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS – ...

The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing ...

Xeris Biopharma (XERS) witnessed a jump in share price last session on above-average trading volume. The latest trend in ...

We recently published a list of 12 Best Stocks to Invest in for a Stock Market Game. In this article, we are going to take a ...

Xeris Biopharma Holdings has received regulatory approval for a new use of its Gvoke liquid glucagon in gastrointestinal ...

Key Insights The projected fair value for Xeris Biopharma Holdings is US$6.17 based on 2 Stage Free Cash Flow to ...

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of ...

Explore Xeris Biopharma's revenue growth, promising pipeline, & thriving products. Learn about their strong outlook & ...